Category | Term | Count | %* | P Valuet | Genes |
Up-regulated | |||||
KEGG_ PATHWAY | hsa04060:Cytokine-cytokine receptor interaction | 28 | 7.272727273 | 5.42E−09 | CXCL1, TNFRSF21, TNFRSF12A, CSF1, CXCL2, TNFSF15, CCL8, TNFRSF8, CX3CL1, TNFRSF11B, TNFRSF1B, IL23A, CCL20, TNFRSF18, CSF3R, IL1B, CSF2RB, PRL, IL1A, IL2RA, IL8, OSM, INHBA, IFNAR2, RELT, TNFRSF10D, CXCL16, PDGFRB |
KEGG_ PATHWAY | hsa05200:Pathways in cancer | 24 | 6.233766234 | 6.57E−05 | FGF18, PLD1, EPAS1, PTGS2, IL8, NFKBIA, NFKB2, BIRC3, RALGDS, MMP1, SHH, IGF1R, RASSF5, CBLB, CDKN1A, CDKN2B, LAMC3, ETS1, ITGAV, SLC2A1, CSF3R, PDGFRB, RUNX1, FGF2 |
KEGG_ PATHWAY | hsa04621:NOD-like receptor signaling pathway | 10 | 2.597402597 | 6.83E−05 | CXCL1, NOD2, IL8, CXCL2, CCL8, NFKBIA, IL1B, RIPK2, TNFAIP3, BIRC3 |
KEGG_ PATHWAY | hsa04640:Hematopoietic cell lineage | 10 | 2.597402597 | 7.80E−04 | IL2RA, GP1BB, ITGA5, CSF1, IL1B, CSF3R, ITGB3, IL1A, HLA-DRA, CD7 |
KEGG_ PATHWAY | hsa04610:Complement and coagulation cascades | 8 | 2.077922078 | 0.003833629 | PLAT, C5AR1, CFB, F3, TFPI, PLAU, F2R, PLAUR |
KEGG_ PATHWAY | hsa04666:Fc gamma R-mediated phagocytosis | 8 | 2.077922078 | 0.020908628 | PLD1, MYO10, FCGR2C, CFL2, SPHK1, ASAP1, FCGR2A, FCGR3A |
KEGG_ PATHWAY | hsa04810:Regulation of actin cytoskeleton | 13 | 3.376623377 | 0.021870623 | GNA13, FGF18, SSH1, MRAS, GNA12, ITGB3, ITGA5, ITGAV, CFL2, ITGB6, PDGFRB, FGF2, F2R |
KEGG_ PATHWAY | hsa04630:Jak-STAT signaling pathway | 10 | 2.597402597 | 0.037676726 | OSM, IFNAR2, CBLB, IL23A, IL2RA, SOCS3, PIM1, CSF2RB, CSF3R, PRL |
KEGG_ PATHWAY | hsa04920:Adipocytokine signaling pathway | 6 | 1.558441558 | 0.045904686 | IRS2, TNFRSF1B, NFKBIE, SOCS3, SLC2A1, NFKBIA |
KEGG_ PATHWAY | hsa04010:MAPK signaling pathway | 14 | 3.636363636 | 0.046369117 | FGF18, MRAS, RELB, GNA12, NFKB2, DUSP4, RASGRP1, GADD45G, MAP3K8, IL1B, PDGFRB, NFATC2, FGF2, IL1A |
Down-regulated | |||||
KEGG_ PATHWAY | hsa00280:Valine, leucine and isoleucine degradation | 14 | 2.337228715 | 5.24E−10 | ALDH6A1, ACADM, BCAT2, EHHADH, BCKDHB, ACAT1, ALDH3A2, HIBADH, DBT, ALDH7A1, IVD, MCCC1, OXCT1, PCCB |
KEGG_ PATHWAY | hsa00640:Propanoate metabolism | 11 | 1.83639399 | 3.10E−08 | ALDH6A1, LDHB, ALDH7A1, ACADM, SUCLG2, EHHADH, ACACA, ACSS2, ACAT1, PCCB, ALDH3A2 |
KEGG_ PATHWAY | hsa00071:Fatty acid metabolism | 9 | 1.502504174 | 3.05E−05 | CPT1C, ALDH7A1, ACADM, EHHADH, ADH5, ADH5P4, ACAT1, ALDH3A2, DCI, CPT1A |
KEGG_ PATHWAY | hsa00310:Lysine degradation | 8 | 1.335559265 | 4.35E−04 | SETDB1, ALDH7A1, EHHADH, SETMAR, TMLHE, ACAT1, ALDH3A2, SUV420H1 |
KEGG_ PATHWAY | hsa00620:Pyruvate metabolism | 7 | 1.168614357 | 0.001551163 | LDHB, ALDH7A1, ACACA, DLAT, ACSS2, ACAT1, ALDH3A2 |
KEGG_ PATHWAY | hsa00010:Glycolysis/ Gluconeogenesis | 8 | 1.335559265 | 0.002853392 | LDHB, GALM, ALDH7A1, ADH5, DLAT, PFKM, ACSS2, ADH5P4, ALDH3A2 |
KEGG_ PATHWAY | hsa00650:Butanoate metabolism | 6 | 1.001669449 | 0.003677294 | ALDH7A1, OXCT1, EHHADH, ACAT1, BDH1, ALDH3A2 |
KEGG_ PATHWAY | hsa00072:Synthesis and degradation of ketone bodies | 3 | 0.500834725 | 0.031809524 | OXCT1, ACAT1, BDH1 |
KEGG_ PATHWAY | hsa00410:beta-Alanine metabolism | 4 | 0.667779633 | 0.031983898 | ALDH7A1, ACADM, EHHADH, ALDH3A2 |
KEGG_ PATHWAY | hsa00380:Tryptophan metabolism | 5 | 0.834724541 | 0.038178672 | ALDH7A1, CYP1B1, EHHADH, ACAT1, ALDH3A2 |
KEGG_ PATHWAY | hsa00980:Metabolism of xenobiotics by cytochrome P450 | 6 | 1.001669449 | 0.0399123 | GSTA4, GSTM4, CYP1B1, GSTK1, ADH5, ADH5P4, GSTM5 |